In vitro susceptibilities of clinical and environmental isolates of Cryptococcus neoformans to five antifungal drugs

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 3, 1996, Pages 822-824

  Franzot, Sarah P ^a   Hamdan, Júnia S ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; KETOCONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE;

EID: 0030069096     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.3.822     Document Type: Article

References (24)

1. Anaisse, E., R. Shawar, V. Paetznick, L. G. Ensign, Z. Witte, and M. LaRocco. 1993. Two-site comparison of broth microdilution and semisolid agar dilution methods for susceptibility testing of Cryptococcus neoformans in three media, J. Clin. Microbiol 31:1370-1372.
2. Barchiesi, F., A. L. Colombo, D. A. McGough, and M. G. Rinaldi. 1994. Comparative study of broth macrodilution and microdilution techniques for in vitro antifungal susceptibility testing of yeasts by using the National Committee for Clinical Laboratory Standards' proposed standard J Clin. Microbiol 32:2494-2500
3. Bava, A. J., and R. Negroni. 1989. Susceptibilidad "in vitro" de cepas de Cryptococcus a 5 drogas antifúngicas. Rev. Inst Med. Trop. Sāo Paulo 31:346-350.
4. Casadevall, A., E. D. Spitzer, D. Webb, and M. G. Rinaldi. 1993. Susceptibilities of serial Cryptococcus neofarmans isolates from patients with recurrent cryptococcal meningitis to amphotericin B and fluconazole. Antimicrob Agents Chemother. 37:1383-1386.
5. Currie, B. P., L. F. Freundlich, and A. Casadevall. 1994. Restriction fragment length polymorphism analysis of Cryptococcus neoformans isolates from environmental (pigeon excreta) and clinical sources in New York City. J. Clin. Microbiol. 32:1188-1192.
6. Espinel-Ingroff, A., T. M. Kerkering, P. R. Goldson, and S. Shadomy. 1991 Comparison study of broth macrodilution and microdilution antifungal susceptibility tests. J. Clin. Microbiol. 29:1089-1094.
7. Espinel-Ingroff, A., C. W. Kish, Jr., T. M. Kerkering, R. A. Fromtling, K. Bartizal, J. N. Galgiani, K. Villareal, M. A. Pfaller, T. Gerarden, M. G. Rinaldi, and A. Fothergill. 1992. Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests J. Clin. Microbiol. 30:3138-3145
8. Espinel-Ingroff, A., and M. A. Pfaller. 1995. Antifungal agents and susceptibility testing, p 1405-1414. In P. R. Murray, E. J. Baron, M A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. American Society for Microbiology, Washington, D C.
9. Fromtling, R. A., G. K. Abruzzo, and A. Ruiz. 1989 Virulence and antifungal susceptibility of environmental and clinical isolates of Cryptococcus neoformans from Puerto Rico. Mycopathologia 106:163-166.
10. Fromtling, R. A., J, N. Galgiani, M. A. Pfaller, A, Espinel-Ingroff, K. F. Bartizal, M. S. Bartlett, B. A. Body, C. Frey, G. Hall, G. D. Roberts, F. B. Nolte, F. C. Odds, M. G. Rinaldi, A. M. Sugar, and K. Villareal. 1993. Multicenter evaluation of a broth macrodilution antifungal susceptibility test for yeasts. Antimicrob. Agents Chemother. 37:39-45.
11. Galgiani, J. N. 1993. Susceptibility testing of fungi current status of the standardization process. Antimicrob. Agents Chemother 37:2517-2521.
12. Ghannoum, M. A., A. S. Ibrahim, Y. Fu, M. C. Shafiq, J. E. Edwards, Jr., and R. S. Criddle. 1992. Susceptibility testing of Cryptococcus neoformans: a microdilution technique. J. Clin Microbiol. 30:2881-2886
13. Kwon-Chung, K. J., and J. W. Fell. 1984. Ftlobasidiellu Kwon-Chung, p. 472-482 In N. J. W Kreger-van Rij (ed.), The yeasts: a taxonomic study, 3rd ed. Elsevier Science publishers B. V., Amsterdam.
14. Kwon-Chung, K. J., I. Polacheck, and J. E. Bennett. 1982 Improved diagnostic medium for separation of Cryptococcys neoformans var neoformans (serotypcs A and D) and Cryptococcu neoformans var. gattu (scrotypes B and C). J. Clin. Microbiol 15:535-537.
15. Lazera, M. S., B. Wanke, and M. M. Nishikawa. 1993. Isolation of both varieties of Cryptococcus neoformans from saprophytic sources in the city of Rio de Janeiro, Brazil. J. Med. Vet. Mycol 31:449-454.
16. Mengoli, C., M. Scarin, M. Peracchi, E. Tonin, and G. Berliato. 1991 Cryptococcus neoformans meningitis in AIDS: in vitro susceptibility to antifungal drugs, abstr. M B.2041. p. 192. In Abstracts of the 1991 International Conference on AIDS
17. Morace, G., B. Posteraro, M. Sanguinetti, A. Ammassari, and E. Tamburrini. 1992. In vitro susceptibility of Cryptococcus neoformans to antifungal drugs. Relationship with clinical outcome of cryptococcosis, abstr. PoB3225, p. 124. In Abstracts of the 1992 International Conference on AIDS.
18. National Committee for Clinical Laboratory Standards. 1992. Reference method for broth dilution antifungal susceptibility testing for yeasts: proposed standard M27-P. National Committee for Clinical Laboratory Standards, Villanova, Pa.
19. Poon, M., D, C. Cronin, G. P. Wormser, and E. J. Bottone. 1988. In vitro susceptibility of Cryptococcus neoformans isolates from patients with acquired immunodeficiency syndrome. Arch. Pathol. Lab. Med. 112:161-162.
20. Rex, J. H., M. A. Pfaller, M. G. Rinaldi, A. Polak, and J. N. Galgiani. 1993. Antifungal susceptibility testing. Clin. Microbiol. Rev. 6:367-381.
21. Rex, J. H., M. G. Rinaldi, and M. A. Pfaller. 1995. Resistance of Candida species to fluconazole Antimicrob. Agents Chemother. 39:1-8.
22. Rozenbaum, R., A. J. R. Gonçalves, B. Wanke, M. J. Caiuby, H. Clemente, M. S. Lazera, P. C. F. Monteiro, and A. T. Londero. 1992. Cryptococcus neoformans varieties as agents of cryptococcosis in Brazil. Mycopathoiogia 119:133-136.
23. Van Cutsem, J., H. Kurata, H. Matsuoka, Y. Mikami, M. A. Pfaller, G. M. Scaralone, and M. G. Rinaldi. 1994. Antifungal drug susceptibility testing J. Med. Vet. Mycol. 32(Suppl. 1):267-276.
24. Wang, Y., and A. Casadevall. 1994. Growth of Cryptococcus neoformans in presence of L-Dopa decreases its susceptibility to amphotericin B. Antimicrob. Agents Chemother 38:2648-2650.